MedPath

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization

Not Applicable
Completed
Conditions
Lymphoma
Interventions
Procedure: socio-aesthetic care
Registration Number
NCT02072655
Lead Sponsor
University Hospital, Angers
Brief Summary

In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase.

In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : " Develop a personalized care taking into account the pain and psychological and social support " and " increase opportunities for patients to benefit from supportive care "and" promote the professional integration .

This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 18 to 65 years old
  • Hospitalized in the Hematology care unit in UH Angers
  • Initial Hodgkin lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma
  • Without previous socio-aesthetic care.
Exclusion Criteria
  • Age <18 years old.
  • Patient protected by the law.
  • Patient at end of life.
  • Patient unable to respond to the questionnaire.
  • Previous Socio aesthetic care.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
with socio-aesthetic caressocio-aesthetic care-
Primary Outcome Measures
NameTimeMethod
Quality of life scoreChange form baseline in Quality of life score at an average of 5 months (4 to 6 cycles of chemotherapy).

* For patients in control group, arbitrarily during their fifth cycle of chemotherapy

* For patients in interventional group during the course of chemotherapy after the third socio-aesthetic care, or at the latest, at the sixth treatment.

Secondary Outcome Measures
NameTimeMethod
Social life assessmentChange form baseline in social life assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).
Coopersmith Self-esteem inventoryChange form baseline in Coopersmith Self-esteem inventory score at an average of 5 months (4 to 6 cycles of chemotherapy).
Body Image Scale assessmentChange form baseline in body image scale assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).

Trial Locations

Locations (1)

Hematology Care Unit - UH Angers

🇫🇷

Angers, France

© Copyright 2025. All Rights Reserved by MedPath